Christoph Thiemermann

The role of the L-arginine: nitric oxide pathway in circulatory shock.

C. Thiemermann, Christoph Thiemermann, C. Thiemermann, 1994, Advances in pharmacology.

Cytokine‐mediated induction of cyclo‐oxygenase‐2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide

C. Thiemermann, J. Vane, Y. S. Bakhle, 1995, British journal of pharmacology.

Nitric oxide and septic shock.

C. Thiemermann, Christoph Thiemermann, C. Thiemermann, 1997, General pharmacology.

5-aminoisoquinolinone, a potent inhibitor of poly (adenosine 5'-diphosphate ribose) polymerase, reduces myocardial infarct size.

M. McDonald, A. Thompson, N. Wayman, 2001, European journal of pharmacology.

Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig.

C. Thiemermann, H. Ruetten, P. Martorana, 1998, European journal of pharmacology.

Selective activation of E-type prostanoid(3)-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandins.

C. Thiemermann, K. Zacharowski, Christoph Thiemermann, 2000, Pharmacology & therapeutics.

Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat.

C. Thiemermann, K. Zacharowski, B. Blackburn, 2001, European journal of pharmacology.